K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity
- PMID: 1730579
K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity
Abstract
The rat pheochromocytoma PC12 cell line differentiates into a sympathetic neuronal phenotype upon treatment with either nerve growth factor (NGF) or basic fibroblast growth factor. The alkaloid-like compound K-252a has been demonstrated to be a specific inhibitor of NGF-induced biological responses in PC12 cells (Koizumi, S., Contreras, M. L., Matsuda, Y., Hama, T., Lazarovici, P., and Guroff, G. (1988) J. Neurosci. Res. 8, 715-721). NGF interacts with the protein product of the proto-oncogene trk and rapidly stimulates the tyrosine phosphorylation of both p140prototrk and a number of cellular substrates. Here we show that these phosphorylation events are directly inhibited in PC12 cells by K252a in a dose-dependent manner, indicating that the site of action of this inhibitor is at the NGF receptor level. K-252a inhibits p140prototrk activity in vitro, demonstrating that K-252a has a direct effect on the p140prototrk tyrosine kinase. Though many of the biochemical responses to NGF in PC12 cells are mimicked by basic fibroblast growth factor and epidermal growth factor, K-252a has no effect on the action of these growth factors in PC12 cells, demonstrating that the initial biological events initiated by NGF are distinctive during neuronal differentiation.
Similar articles
-
Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF.Nature. 1991 Mar 14;350(6314):158-60. doi: 10.1038/350158a0. Nature. 1991. PMID: 1706478
-
SNT, a differentiation-specific target of neurotrophic factor-induced tyrosine kinase activity in neurons and PC12 cells.Mol Cell Biol. 1993 Apr;13(4):2203-13. doi: 10.1128/mcb.13.4.2203-2213.1993. Mol Cell Biol. 1993. PMID: 7681142 Free PMC article.
-
K-252b selectively potentiates cellular actions and trk tyrosine phosphorylation mediated by neurotrophin-3.J Neurochem. 1992 Aug;59(2):715-22. doi: 10.1111/j.1471-4159.1992.tb09427.x. J Neurochem. 1992. PMID: 1629741
-
Selective inhibition of nerve growth factor-stimulated protein kinases by K-252a and 5'-S-methyladenosine in PC12 cells.J Neurochem. 1989 Sep;53(3):800-6. doi: 10.1111/j.1471-4159.1989.tb11776.x. J Neurochem. 1989. PMID: 2547901
-
The trk family of oncogenes and neurotrophin receptors.Princess Takamatsu Symp. 1991;22:153-70. Princess Takamatsu Symp. 1991. PMID: 1844238 Review.
Cited by
-
Effects of axotomy on cultured sensory neurons of Aplysia: long-term injury-induced changes in excitability and morphology are mediated by different signaling pathways.J Neurophysiol. 2008 Dec;100(6):3209-24. doi: 10.1152/jn.90539.2008. Epub 2008 Oct 8. J Neurophysiol. 2008. PMID: 18842953 Free PMC article.
-
Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness.Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7859-63. doi: 10.1073/pnas.90.16.7859. Proc Natl Acad Sci U S A. 1993. PMID: 8356095 Free PMC article.
-
Protein kinase-dependent effects of okadaic acid on hepatocytic autophagy and cytoskeletal integrity.Biochem J. 1992 Jun 15;284 ( Pt 3)(Pt 3):633-6. doi: 10.1042/bj2840633. Biochem J. 1992. PMID: 1320371 Free PMC article.
-
Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor.Invest New Drugs. 2005 Jan;23(1):31-7. doi: 10.1023/B:DRUG.0000047103.64335.b0. Invest New Drugs. 2005. PMID: 15528978 Clinical Trial.
-
Nerve growth factor transfer from cardiomyocytes to innervating sympathetic neurons activates TrkA receptors at the neuro-cardiac junction.J Physiol. 2022 Jun;600(12):2853-2875. doi: 10.1113/JP282828. Epub 2022 Apr 30. J Physiol. 2022. PMID: 35413134 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
